Study of Topical SOR007 Ointment for Cutaneous Metastases
Status:
Completed
Trial end date:
2020-04-29
Target enrollment:
Participant gender:
Summary
This study evaluates a topical nanoparticle paclitaxel ointment (SOR007) for the treatment of
cutaneous metastases from non-melanoma cancer in adults. Three concentrations of SOR007 will
be evaluated in dose-rising cohorts of three. An expanded cohort will treat additional
subjects at the maximum tolerated dose.